We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Just a bit of a throw away observation, but I did notice in the FOFH RNS that ABDX highlighted they will have rights to offer the STI tests as own brand retailer products, and you have to wonder if they have Boots in mind. Whatever the case, its clear that retailer own branding is something ABDX are pursuing and, of course, we can offer exactly the same test ( I think) to multiple retailers as an own brand product.
Lol, so glad I'm on your team, Muck. I'm going to make a pretty decent profit here because I now think I know all there is to know about this investment. You're a God-send. Have a great day!
In that vein, and to give a flavour, BBI were sold in 2021 for £400m.
Should be remembered that they provide antibodies, antigens, labels, and complementary reagents, as well as do everything ABDX does. But still…..
https://www.prnewswire.com/news-releases/novo-holdings-acquires-bbi-group-301312183.html#:~:text=COPENHAGEN%2C%20Denmark%2C%20June%2015%2C,value%20of%20over%20GBP%20400
Well said, and in fewer words than I normally manage! Maybe I should try the wine.
Longer term, well more medium term I think, I expect that Chris Hand will be looking for a capital exit. He’s already built, AIM listed and then sold one drugs of abuse LFT diagnostics company (Cozart, now part of Abbot) for £65m, and he must be looking at ABDX as his juicy retirement fund. He’s 63 next month.
It's all quite extraordinary really. I have to pinch myself at such a find. You once worried about the "sexiness" of what they have to offer, but for me, its the solidity, quality, vision and potential for growth that is most exciting. We can all latch onto the latest hype-driven trend and watch stocks rise, drop or even fall by the wayside, but IMO this is a company that will stay the distance and prosper and I think 78p in the nearish future is more than likely. Sex appeal works, business brains are better! (Been on the wine again!)
For awareness btw, there is a company called AbcDx that are trying to do exactly what Upfront are. They are being assisted by BBI (one of our major competitors), but seem to me to be AT LEAST 6 months behind Upfront.
https://www.abcdx.ch/solution/lvocheck
https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2023.1327348/full
TBH I think one advantage here is that unlike many other stocks, we’re not waiting on a single catalyst but instead have our fingers in so many pies. At the moment I’m watching out for any news on;
Septiloop sales/take up.
Salistick launch in new territories and possibly FDA authorisation. Equally any new U.K. retailers
Upfront funding and UKCA
Another own label Boots product(s)
News on EcoFlo pro type testing/results and possible commercial launch
And this is all just what’s on my radar for Q2/3, and ignores 52North, FOFH, and any other surprises we know nothing about.
I never put too much store in analyst predictions but 78p really doesn’t sound ridiculous to me as a 12 month target. If we were to do it though, the beauty is that it should be founded on solid year on year annuity income.
And as I’ve said before, our risk is spread widely across customers who have all spent years getting to where they are, and who therefore have every incentive to achieve commercial success.
This is the interesting drop before buys suddenly increase lol. Been waiting for this so I can buy my last batch. Win, win I say. I wonder who's buying in tomorrow?
I bet you're right, my last buy was listed as a sale....
Onwards and upwards Monk...
Wow Muck, that sounds like a huge catalyst for the raise in share price we are all expecting.Im really looking forward to the trading results for the rest of this year. The market can't ignore us for much longer.
Don't think so Ant - Everything at 10.34 is definitely a buy, and I suspect so are those at 10.12.
Only the trades at 10 dead are sells I think.
A lot of little sales, a bit of impatience setting in....
Keep the faith this stock is on the verge of big things....
Another observation, this time just a post from Upfront.
https://www.linkedin.com/posts/upfrontdiagnostics_timeislife-activity-7188440790136676352-hZJU?utm_source=share&utm_medium=member_desktop
Upfront have been working with North East NHS Hospitals since 2018 and, as you can see from the post, that means they have built a product that not only works, but has been made specifically for use in the NHS. Its little wonder they were selected for the IDAP scheme and their LVOne test is, for my money, destined for widespread NHS adoption. The next I think we will hear from Upfront, which I suspect will come pretty shortly, is a successful latest funding round. Then it will be UKCA this quarter and then very quick NHS adoption and ergo manufacturing requirements.
Worth noting again that Upfront have been telling people that they can manufacture at scale. Well, we are their only manufacturing partner as far as I can tell.
Let's hope that comes true for all LTs here.
Exactly. "The 12 month price target for Abingdon Health PLC's share price is to rise to 78.00 in the next year from the last price of 10.50". Happy days....
Good luck, Brighty
Woo hoo, from a 56p target to 78p!
Someone out there knows even more than Muck165
https://markets.investorschronicle.co.uk/data/equities/tearsheet/forecasts?s=ABDX:LSE#:~:text=Share%20price%20forecast,the%20last%20price%20of%2010.50.
Don't think they need any big firms circulating round them, to be honest. Reckon they have the potential to be big enough all by themselves.
I am surprised no big firms are circulating , Abingdon have so many different options they are looking into ,some big firm must have noticed this or maybe keeping track of what’s going on,in time a bid may materialise,but at what price.
Another observation…
It would appear that Salignostics have become a client of Sheng Enterprises, a Chinese company helping Israeli companies get a foothold in the Chinese market. More detail can be found here under the March 24 event “ The Israel Medical Device Special Matchmaking Event” - https://www.sheng-cn.com.cn/events-meetings/.
More on Sheng generally here - https://www.sheng-cn.com.cn/
More for awareness really
Please please CY give us some news!
Been showing rapid growth in recent years and been stuck at 10p for a while buying pressure in recent weeks should eventually win a push this upto 20p hoping this week will be the week for that
Just another little observation….
ABDX latest blog was about security of supply chain, written by our COO Mark Jones - https://www.abingdonhealth.com/ensuring-your-critical-components-are-protected-the-importance-of-supply-agreements/
Whist this is undated, it appears to me to be a new news release from a company called Rosti, who have partnered with is for injection moulding.
https://rosti.com/rosti-uk-secures-exciting-new-project-with-abingdon-health/
Just interesting that focus lately has been on supply and security of manufacturing components.
I see Wynbore is still trying to get a foothold..
Set your phasers to stun lol
Goodness, springing upwards week by week. Won't be long now!
In that case we need to get 80p...... so £8m-12m profit to support that price, I guess.
12 months ... (maybe....) :0))
(Just my opinion DYOR etc)